BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.770
-0.260 (-12.81%)
At close: Jun 27, 2025, 4:00 PM
1.860
+0.090 (5.08%)
After-hours: Jun 27, 2025, 7:39 PM EDT

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $10.72 million as of June 27, 2025. Its market cap has decreased by -80.17% in one year.

Market Cap
10.72M
Enterprise Value
85.58M
1-Year Change
-80.17%
Ranking
Category
Stock Price
$1.77

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $10.72M, a decrease of -93.79%. That is a compound annual growth rate of -31.63%.

History

DateMarket Cap% Change
Jun 26, 202512.29M-33.75%
Dec 31, 202418.56M-78.51%
Dec 29, 202386.35M-85.65%
Dec 30, 2022601.94M5.82%
Dec 31, 2021568.84M-49.47%
Dec 31, 20201.13B327.27%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 709.19B
Johnson & Johnson 368.35B
AbbVie 331.70B
Novo Nordisk 301.06B
UnitedHealth Group 276.61B
Abbott Laboratories 239.12B
Novartis AG 231.01B
AstraZeneca 216.45B
Market Cap Rankings